Annovis Bio, Inc. — Director's Dealing 2021

Jul 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Annovis Bio, Inc. (ANVS)
CIK: 0001477845
Period of Report: 2021-07-07

Reporting Person: White Mark K. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-07	Stock Option (right to buy)	$102.85	A	4000	Acquired	2031-07-07	Common Stock (4000)	Direct

Footnotes

F1: The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to serve as a director of the issuer on the applicable vesting date.